{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T17:05:34Z","timestamp":1748365534544},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6,1]]},"DOI":"10.1093\/jjco\/hyw029","type":"journal-article","created":{"date-parts":[[2016,3,14]],"date-time":"2016-03-14T20:08:20Z","timestamp":1457986100000},"page":"517-521","source":"Crossref","is-referenced-by-count":11,"title":["A preoperative low cancer antigen 125 level (\u226425.8 mg\/dl) is a useful criterion to determine the optimal timing of interval debulking surgery following neoadjuvant chemotherapy in epithelial ovarian cancer"],"prefix":"10.1093","volume":"46","author":[{"given":"Akemi","family":"Morimoto","sequence":"first","affiliation":[{"name":"Department of Gynecologic Oncology, Hyogo Cancer Center, Akashi, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Nagao","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, Hyogo Cancer Center, Akashi, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Kogiku","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, Hyogo Cancer Center, Akashi, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasumi","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, Hyogo Cancer Center, Akashi, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiko","family":"Miwa","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, Hyogo Cancer Center, Akashi, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senn","family":"Wakahashi","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, Hyogo Cancer Center, Akashi, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Ichida","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, Hyogo Cancer Center, Akashi, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamotsu","family":"Sudo","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, Hyogo Cancer Center, Akashi, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, Hyogo Cancer Center, Akashi, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, Hyogo Cancer Center, Akashi, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,6,28]]},"reference":[{"key":"key\n\t\t\t\t2018110810575109100_HYW029C1","first-page":"10","article-title":"An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT)","volume":"124","author":"Chi","year":"2012","journal-title":"Gynecol Oncol"},{"key":"key\n\t\t\t\t2018110810575109100_HYW029C2","first-page":"103","article-title":"Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study","volume":"69","author":"Eisenkop","year":"1998","journal-title":"Gynecol Oncol"},{"key":"key\n\t\t\t\t2018110810575109100_HYW029C3","first-page":"8802","article-title":"Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 trial","volume":"23","author":"Crawford","year":"2005","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2018110810575109100_HYW029C4","first-page":"629","article-title":"The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for research and Treatment of Cancer","volume":"332","author":"van der Burg","year":"1995","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018110810575109100_HYW029C5","first-page":"943","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018110810575109100_HYW029C6","first-page":"362","article-title":"Changes in serum CA-125 can predict optimal cytoreduction to no gross residual disease in patients with advanced stage ovarian cancer treated with neoadjuvant chemotherapy","volume":"125","author":"Rodriguez","year":"2012","journal-title":"Gynecol Oncol"},{"key":"key\n\t\t\t\t2018110810575109100_HYW029C7","first-page":"141","article-title":"CA-125 cut-off value as a predictor for complete interval debulking surgery after neoadjuvant chemotherapy in patients with advanced ovarian cancer","volume":"24","author":"Furukawa","year":"2013","journal-title":"J Gynecol Oncol"},{"key":"key\n\t\t\t\t2018110810575109100_HYW029C8","first-page":"991","article-title":"Recurrence patterns of advanced ovarian, fallopian tube, and peritoneal cancers after complete cytoreduction during interval debulking surgery","volume":"24","author":"Usami","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"key\n\t\t\t\t2018110810575109100_HYW029C9","first-page":"324","article-title":"Residual cancer stem cells after interval cytoreductive surgery following neoadjuvant chemotherapy could result in poor treatment outcomes for ovarian cancer","volume":"33","author":"Lim","year":"2010","journal-title":"Onkologie"},{"key":"key\n\t\t\t\t2018110810575109100_HYW029C10","first-page":"1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2018110810575109100_HYW029C11","first-page":"88","article-title":"Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer","volume":"47","author":"Vergote","year":"2011","journal-title":"Eur J Cancer"},{"key":"key\n\t\t\t\t2018110810575109100_HYW029C12","first-page":"6","article-title":"A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma","volume":"112","author":"Chi","year":"2009","journal-title":"Gynecol Oncol"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/46\/6\/517\/26443724\/hyw029.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T10:57:58Z","timestamp":1541674678000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/46\/6\/517\/2412376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,1]]},"references-count":12,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,28]]},"published-print":{"date-parts":[[2016,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyw029","relation":{},"ISSN":["1465-3621","0368-2811"],"issn-type":[{"value":"1465-3621","type":"electronic"},{"value":"0368-2811","type":"print"}],"subject":[],"published-other":{"date-parts":[[2016,6]]},"published":{"date-parts":[[2016,6,1]]}}}